New study shows how genes control blood proteins important to health

A new study shows how genes control levels of many blood proteins implicated in disease. The findings are the result of an international collaboration between scientists at the University of Exeter, the National Institute on Aging, and the Tuscany and Florence Health Agencies. Details, published May 9th in the open-access journal PLoS Genetics, determine how many of the key proteins within our blood are under genetic control, showing that diet and lifestyle are not the only factors influencing its makeup.

Maintaining the correct proportions of proteins, fats and other molecules in our blood is critical for normal health. An obvious example is cholesterol: high blood levels of “bad” LDL cholesterol and low blood levels of “good” HDL cholesterol increase the risk of heart disease. Previous studies have shown how cholesterol levels are not only influenced by diet and lifestyle but are also under strong genetic control.

This latest study, involving the entire genome, shows how blood levels of many other proteins are under strong genetic control. These proteins include a class of molecules called “interleukins” that are important in inflammatory diseases such as multiple sclerosis and rheumatoid arthritis. Interleukins may also play a role in heart disease and related “metabolic” disorders.

As an example, the group identified variations in genes that influence “Sex hormone binding globulin,” a protein that controls how much testosterone is freely available in one’s blood. As another example, the group identified variations in genes that influence “Macrophage inflammatory protein beta” (MIP-beta), a protein that may play a role in influencing how likely people with HIV infection will go on to develop AIDS. The identification of these genes could lead to a greater understanding of the diseases they are implicated in.

“By identifying versions of genes that alter blood levels of important molecules we should be able to understand whether these molecules are important in disease processes or not,” said Professor Tim Frayling, one of the study’s leaders.

In this comprehensive study the researchers studied a total of 42 circulating proteins. The findings make way for future studies focusing on how the whole genome influences all proteins, not just those that end up circulating in the blood, although these are some of the most important from a disease perspective.

Citation: Melzer D, Perry JRB, Hernandez D, Corsi A-M, Stevens K, et al. (2008) A Genome-Wide Association Study Identifies Protein Quantitative Trait Loci (pQTLs). PLoS Genet 4(5): e1000072. doi:10.1371/journal.pgen.1000072

Source: Public Library of Science

Related stories:

Gene directs stem cells to build the heart
Researchers have shown that they can put mouse embryonic stem cells to work building the heart, potentially moving medical science a significant step closer to a new generation of heart disease treatments that use human stem cells.
UC researchers find new ways to regulate genes, reduce heart damage
Researchers at the University of Cincinnati (UC) are looking for ways to reduce or prevent heart damage by starting where the problem often begins: in the genes.
Unexpected finding of molecule's dual role in mice may open new avenue to cholesterol reduction
Researchers have discovered an unknown regulator of fat and cholesterol production in the liver of mice, a significant finding that could lead to new therapies for lowering unhealthy blood levels of cholesterol and fats.
On the evolutionary trail of molecules that cause Lou Gehrig's disease
What became a scientific quest for Dr. Hugo Bellen and his colleagues at Baylor College of Medicine in Houston began with trying to define the function of a protein that plays a role in the nervous system.
Vitamin D: New way to treat heart failure?
Strong bones, a healthy immune system, protection against some types of cancer: Recent studies suggest there's yet another item for the expanding list of vitamin D benefits. Vitamin D, "the sunshine vitamin," keeps the heart, the body's long-distance runner, fit for life's demands.
Cancer-killing viruses influence tumor blood-vessel growth
Viruses genetically designed to kill cancer cells offer a promising strategy for treating incurable brain tumors such as glioblastoma, but the body's natural defenses often eliminate the viruses before they can eliminate the tumor.
Microenvironment a main driver of aggressive multi-lineage leukemia disease type
Research led by scientists at Cincinnati Children's Hospital Medical Center has revealed new clues into what causes different types of a particularly aggressive group of blood cancers known as mixed lineage leukemias (MLL) and how the disease might be treated, according to a study in the June 9 issue of Cancer Cell.
MicroRNA controls expression of oncogenes
A new study demonstrates that microRNAs can modulate the expression of well known tumor-specific oncogenic translocation proteins and may play a significant role in some human cancers. The research, published by Cell Press in the June issue of the journal Cancer Cell, is likely to lead to new strategies for treating some specific lymphomas and leukemias.

News discussion:

Medicine & Health news